Interpretation of serologic tests in an HIV-infected patient with kidney disease

Nature Clinical Practice Nephrology

Volumn 2, Issue 12, 2006, Pages 708-712

  Hernandez, German T ^a,b   Critchfield, Jeffrey M ^b   Rodriguez, Rudolph A ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti glomerular basement membrane antibody; Anti myeloperoxidase antibodies; Hemoptysis; HIV infection; Renal insufficiency

Indexed keywords

CEFTRIAXONE; ENZYME ANTIBODY; ETHAMBUTOL; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; ISONIAZID; MYELOPEROXIDASE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; VIRUS RNA;

ADULT; AFRICAN AMERICAN; AIDS RELATED COMPLEX; ARTICLE; BLOOD ANALYSIS; BRONCHOSCOPY; CASE REPORT; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ECHOGRAPHY; FALSE POSITIVE RESULT; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY DIAGNOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL METHOD; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULOSIS; URINALYSIS; VIRUS REACTIVATION;

ADULT; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MALE; SEROLOGIC TESTS;

EID: 33845256031     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0324     Document Type: Article

References (27)

1. Bourgoignie JJ et al. (1988) The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 12: 131-137
2. D'Agati V et al. (1997) HIV infection and the kidney. J Am Soc Nephrol 8: 138-152
3. Szczech LA et al. (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152
4. Gisselbrecht M et al. (1998) Human immunodeficiency virus-related vasculitis: clinical presentation of and therapeutic approach to eight cases. Ann Med Interne (Paris) 149: 398-405
5. Kaye BR (1989) Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med 111: 158-167
6. Monteiro EJ et al. (2006) Anti-glomerular basement membrane glomerulonephritis in an HIV positive patient: case report. Braz J Infect Dis 10: 55-58
7. Koderisch J et al. (1990) "False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet 335: 1227-1228
8. Klaassen RJ et al. (1992) Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87: 24-30
9. Savige JA et al. (1994) Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 18: 205-211
10. Bonnet F et al. (2003) Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. J Rheumatol 30: 2005-2010
11. Dimitrakopoulos AN et al. (1999) Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 130: 226-230
12. Ng VL (1996) B-lymphocytes and autoantibody profiles in HIV disease. Clin Rev Allergy Immunol 14: 367-384
13. Monroe JG et al. (1995) HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 15: 61-68
14. Lane HC et al. (1983) Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309: 453-458
15. Glassock R (2000) Management of rapidly progressive glomerulonephritis. Hosp Pract (Minneap ) 35: 59-62, 65-66, 69-70
16. Lucas GM et al. (2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18: 541-546
17. Smith MC et al. (1996) Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101: 41-48
18. Wei A et al. (2003) Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64: 1462-1471
19. Gupta SK et al. (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40: 1559-1585
20. Cheng JT et al. (1999) Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 10: 1566-1574
21. Haas M et al. (2005) HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases. Kidney Int 67: 1381-1390
22. Hughes CA et al. (2006) Treatment of hepatitis C in HIV-coinfected patients. Ann Pharmacother 40: 479-489
23. Romanelli F et al. (2006) Use of virostatics as a means of targeting human immunodeficiency virus infection. Curr Pharm Des 12: 1121-1127
24. Kumar MS et al. (2005) Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 67: 1622-1629
25. Garcia F et al. (2004) Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study. J Acquir Immune Defic Syndr 36: 823-830
26. Douek DC et al. (2003) T cell dynamics in HIV-1 infection. Annu Rev Immunol 21: 265-304
27. Pasare C et al. (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036